ARCHIVES

Cancer Survivorship: NCI, Komen, OWH Fund Research Grants

This article is from The Cancer Letter archive.

Vol. 23 No. 46 | December 5, 1997

Download PDF Visit The Full Archive

Related Articles

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

European regulators plan more rigorous rules for accelerated approval in cancer.

November 11, 2005

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Jill ElkenberryTo Get ACCC Award

March 17, 1989

In Brief: Biomedical Panel Report Will Support Cancer Program, Targeted Research

January 16, 1976

Clearinghouse Finds Five Compounds Pose Risk To Humans

March 2, 1979